Publication and Presentation. (a) Notwithstanding anything to the contrary in this Section 1.11, Institution and Investigator have the right to publish the results of a Study conducted at Institution subject to the terms and conditions of this Section 1.11.
Publication and Presentation. PRIME RECIPIENT, or its employees or students, may issue publications or give presentations based on the statement(s) of work of the Prime or Subaward, excluding the Confidential Information of SUBRECIPIENT. PRIME RECIPIENT will provide SUBRECIPIENT an opportunity for thirty (30) days prior to the proposed submission of any publication or the delivery of any presentation to review such publication and, if necessary, request PRIME RECIPIENT to delete any reference to SUBRECIPIENT’S Confidential Information. Furthermore, SUBRECIPIENT shall have the right to request a delay in publication or presentation for up to thirty (30) additional days, if necessary, to allow for filing of patents if such publication or presentation contains patentable subject matter. The right of review SUBRECIPIENT has under this Section shall terminate twelve (12) months from completion of the Subaward, except with respect to any review required consistent with Section 2(b). In no event shall any of SUBRECIPIENT’S Confidential Information be included in any publication or presentation without written authorization from SUBRECIPIENT.
Publication and Presentation. (i) If either party desires to publish or present the results of the Development Program, the publishing / presenting party shall provide the non-publishing / non-presenting party with a copy of the manuscript of the proposed publication or presentation at least [***] prior to such publication or presentation. The non-publishing / non-presenting party shall then review such manuscript or presentation by providing the publishing / presenting party with comments, if any, as soon as possible, but in no event to exceed [***] after receipt of such manuscript or presentation. The publishing / presenting party agrees to delete any information identified by the non-publishing / non-presenting party as its Trade Secrets or Confidential Information.
Publication and Presentation. (i) If either party desires to publish or present the results of the Development Program, the publishing / presenting party shall provide the non-publishing / non-presenting party a copy of the manuscript of any proposed publication or presentation. The non-publishing / non-presenting party shall then have thirty (30) days to review and comment on the manuscript or presentation, and the publishing / presenting party agrees to delete any information identified by the non-publishing / non-presenting party as its Trade Secrets or Confidential Information.
Publication and Presentation. The Study being conducted under this Agreement is part of the Overall Study. Subject to the restrictions in this Section 10.0, each Investigator may publish in reputable journals or may present at professional conferences Study Results from his/her respective Site, but only after (a) the results of the Overall Study in its entirety have been published by or with the consent of BIND in an abstract or manuscript, or (b) eighteen (18) months after conclusion of the Overall Study at all investigational research sites for the Overall Study, whichever first occurs first.
Publication and Presentation. 6.1 LTI acknowledges that a basic objective of research activities performed by Yissum and Yissum Personnel is the generation and dissemination of new knowledge, and the commercialization thereof.
Publication and Presentation. Enumeral shall have no right hereunder to publish or present any of the Merck Information including, without limitation, Study Results, without first providing any such publication or presentation to Merck for prior review and written approval from Merck; and Enumeral shall have no right to prevent publication or presentation by Merck or its Affiliates of the Merck Information including, without limitation, Study Results. In the event of a publication or presentation by Merck or its Affiliates of the Merck Information, including the Study Results, Merck will use reasonable efforts to acknowledge Enumeral in such materials.
Publication and Presentation. Manuscripts to be submitted for review, as well as research findings submitted for presentation at professional meetings, must be reviewed by the Executive Director prior to submission. This is not a scientific review, and is only intended to bring to light any information that might be proprietary or require risk management efforts on the part of the organization so that information and any response can be most effectively managed. Authorship decisions should follow commonly-accepted guidance (e.g., ICJME xxxx://xxx.xxxxx.xxx/recommendations/browse/roles-and-responsibilities/defining-the-role- of-authors-and-contributors.html) and a KPGA investigator should contribute meaningfully and with attribution. Researchers using the Center's core data systems will acknowledge the Center's development and maintenance of those systems in their reports and publications. Sources of financial support for research will be acknowledged in reports and publications of the research unless the funding source requests that acknowledgement not be given. All manuscripts or presentations using KPGA data and/or funds must be reviewed prior to submission.
Publication and Presentation
